Home > Cardiology > Cryoablation Afib studies show better first-line outcomes than drug therapy

Cryoablation Afib studies show better first-line outcomes than drug therapy


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Journal
New England Journal of Medicine
Conference
AHA 2020
Reuters Health - 16/11/2020 - Two studies examining cryoablation as first-line therapy for patients with atrial fibrillation have concluded that the cryoballoon procedure lowers the risk of Afib by as much as 52% compared with conventional drug treatment. "It's clear that the sooner we intervene, the better the outcomes," Dr. Oussama Wazni of the Cleveland Clinic in Ohio, who is chief author of the STOP-AF study, told Reuters Health in a telephone interview. "I think this will change the guidelines," which currently recommend ablation only if drug therapy fails. He also predicted that trying ablation first will save money over the long term because "a big percentage of patients in the drug group ended up with ablation anyway, so there's no cost savings" to trying drugs first. The erratic heartbeat of atrial fibrillation makes the likelihood of stroke five- to seven-times greater. The condition affects roughly 1% to 2% of the population. With cryoablation, a s...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on